Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol Opioid-Induced Bowel Dysfunction
2022-500108-23-00Phase 4Completed
- Sponsor
- Aalborg University Hospital
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tramadol in opioid-induced bowel dysfunction (OIBD) (2 arms), sponsored by Aalborg University Hospital. Primary endpoints: Total gastrointestinal transit time and Colorectal transit time. Started May 2022; status: completed.
02
Drugs
tramadol
03
Conditions
opioid-induced bowel dysfunction (OIBD)
Beyond the preview
Go deeper on 2022-500108-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500108-23-00.